Novartis and Broad Institute researchers explore how gut bacteria contribute to health and disease, beginning with type 1 diabetes.

Learn how Novartis researchers are working to outsmart tumors.

Learn about the career of our Global Medical Affairs Head for Solid Tumors and Rare Diseases.

Industry labs find that, contrary to earlier evidence, KRAS-driven tumors are not addicted to autophagy.

Gervais Tougas shares his experience working on a Novartis task force dedicated to fighting the COVID-19 pandemic.

A reversal in thinking about the reversibility of liver damage is changing the field of hepatology.

Read how a genetics postdoctoral researcher finds Huntington's mutation travels through neural circuits.